- Home
- LWLG vs PROK Comparison
LWLG vs PROK Comparison
Compare LWLG & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LWLG
- PROK
- Stock Information
- Founded
- LWLG 1991
- PROK 2015
- Country
- LWLG United States
- PROK United States
- Employees
- LWLG N/A
- PROK N/A
- Industry
- LWLG Containers/Packaging
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- LWLG Industrials
- PROK Health Care
- Exchange
- LWLG Nasdaq
- PROK Nasdaq
- Market Cap
- LWLG 126.0M
- PROK 129.5M
- IPO Year
- LWLG N/A
- PROK N/A
- Fundamental
- Price
- LWLG $1.22
- PROK $0.71
- Analyst Decision
- LWLG
- PROK Buy
- Analyst Count
- LWLG 0
- PROK 3
- Target Price
- LWLG N/A
- PROK $4.50
- AVG Volume (30 Days)
- LWLG 1.1M
- PROK 667.1K
- Earning Date
- LWLG 08-08-2025
- PROK 08-08-2025
- Dividend Yield
- LWLG N/A
- PROK N/A
- EPS Growth
- LWLG N/A
- PROK N/A
- EPS
- LWLG N/A
- PROK N/A
- Revenue
- LWLG $88,105.00
- PROK $306,000.00
- Revenue This Year
- LWLG N/A
- PROK $54.34
- Revenue Next Year
- LWLG N/A
- PROK N/A
- P/E Ratio
- LWLG N/A
- PROK N/A
- Revenue Growth
- LWLG 24.23
- PROK N/A
- 52 Week Low
- LWLG $0.79
- PROK $0.46
- 52 Week High
- LWLG $4.23
- PROK $2.75
- Technical
- Relative Strength Index (RSI)
- LWLG 54.57
- PROK 44.48
- Support Level
- LWLG $1.21
- PROK $0.69
- Resistance Level
- LWLG $1.36
- PROK $1.02
- Average True Range (ATR)
- LWLG 0.12
- PROK 0.11
- MACD
- LWLG 0.01
- PROK -0.01
- Stochastic Oscillator
- LWLG 59.18
- PROK 13.58
About LWLG Lightwave Logic Inc.
Lightwave Logic Inc is a United States-based development stage company moving toward commercialization of next-generation electro-optic photonic devices made on its P2IC technology platform which uses in-house proprietary high-activity and high-stability organic polymers. Electro-optical devices convert data from electric signals into optical signals for multiple applications. It designs and synthesizes organic chromophores for use in its own proprietary electro-optic polymer systems and photonic device designs.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.